Oncolytics Biotech (TSE:ONC) has released an update.
Oncolytics Biotech Inc., a leader in immunotherapy for cancer, has announced its participation in a fireside chat at the upcoming RBC Capital Markets Global Healthcare Conference on May 15, 2024. Dr. Matt Coffey, the CEO, will represent the company, which is known for developing pelareorep, an innovative anti-cancer agent that has shown promise in early-stage clinical trials. The event will be webcasted live and is accessible through the company’s Investor Relations page, with archived content available for future viewing.
For further insights into TSE:ONC stock, check out TipRanks’ Stock Analysis page.
